The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company's current EPS (TTM) is 13,05 €. In 2022 the company made an earnings per share (EPS) of 11,24 € an increase over its 2021 EPS that were of 9,56 €.